Genetic testing revealed a heterozygous serine threonine kinase 11 germline mutation and there were no signs of recurrence during the 18-month follow-up period after treatment.<h4>Conclusions</h4>This is a rare case in which PJS was complicated by SMMN-FGT. This evidence concerns the gene MARK2 and Peutz-Jeghers syndrome.